These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The role of spinal cholecystokinin in chronic pain states. Wiesenfeld-Hallin Z; Xu XJ; Hökfelt T Pharmacol Toxicol; 2002 Dec; 91(6):398-403. PubMed ID: 12688385 [TBL] [Abstract][Full Text] [Related]
24. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Bradwejn J; Koszycki D; Shriqui C Arch Gen Psychiatry; 1991 Jul; 48(7):603-10. PubMed ID: 2069490 [TBL] [Abstract][Full Text] [Related]
25. Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosa. Heinemann A; Jocic M; Holzer-Petsche U; Pethö G; Peskar BM; Horwell DC; Holzer P Br J Pharmacol; 1995 Oct; 116(4):2274-8. PubMed ID: 8564259 [TBL] [Abstract][Full Text] [Related]
26. Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion. Hebb AL; Poulin JF; Roach SP; Zacharko RM; Drolet G Prog Neuropsychopharmacol Biol Psychiatry; 2005 Dec; 29(8):1225-38. PubMed ID: 16242828 [TBL] [Abstract][Full Text] [Related]
27. Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety. Rex A; Barth T; Voigt JP; Domeney AM; Fink H Neurosci Lett; 1994 May; 172(1-2):139-42. PubMed ID: 8084519 [TBL] [Abstract][Full Text] [Related]
28. Discovery of a cholecystokinin-gastrin-like signaling system in nematodes. Janssen T; Meelkop E; Lindemans M; Verstraelen K; Husson SJ; Temmerman L; Nachman RJ; Schoofs L Endocrinology; 2008 Jun; 149(6):2826-39. PubMed ID: 18339709 [TBL] [Abstract][Full Text] [Related]
29. Cholecystokinin and anxiety: promises and pitfalls. Rodgers RJ; Johnson NJ Crit Rev Neurobiol; 1995; 9(4):345-69. PubMed ID: 8829850 [TBL] [Abstract][Full Text] [Related]
30. [Cholecystokinin and cholecystokinin receptor]. Funakoshi A Nihon Rinsho; 1996 Apr; 54(4):1097-1103. PubMed ID: 8920681 [TBL] [Abstract][Full Text] [Related]
31. CSF cholecystokinin, gamma-aminobutyric acid and neuropeptide Y in pathological gamblers and healthy controls. Nordin C; Sjödin I J Neural Transm (Vienna); 2007; 114(4):499-503. PubMed ID: 17109076 [TBL] [Abstract][Full Text] [Related]
32. Multiple cholecystokinin (CCK) receptors and CCK-monoamine interactions are instrumental in the control of feeding. Cooper SJ; Dourish CT Physiol Behav; 1990 Dec; 48(6):849-57. PubMed ID: 1982361 [TBL] [Abstract][Full Text] [Related]
33. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion. Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253 [TBL] [Abstract][Full Text] [Related]
34. Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum. Snyder GL; Fisone G; Morino P; Gundersen V; Ottersen OP; Hökfelt T; Greengard P Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11277-81. PubMed ID: 8248241 [TBL] [Abstract][Full Text] [Related]
35. Major biological actions of CCK--a critical evaluation of research findings. Fink H; Rex A; Voits M; Voigt JP Exp Brain Res; 1998 Nov; 123(1-2):77-83. PubMed ID: 9835394 [TBL] [Abstract][Full Text] [Related]
38. Vasodilatory effects of cholecystokinin: new role for an old peptide? Ruiz-Gayo M; González MC; Fernández-Alfonso S Regul Pept; 2006 Dec; 137(3):179-84. PubMed ID: 16889840 [TBL] [Abstract][Full Text] [Related]
39. [Advances in gastrointestinal hormones: cholecystokinin]. Ubilluz R Rev Gastroenterol Peru; 1994; 14(3):222-32. PubMed ID: 8000026 [TBL] [Abstract][Full Text] [Related]
40. Evidence for two cholecystokinin receptors mediating the contraction of the guinea pig isolated ileum longitudinal muscle myenteric plexus. Dal Forno G; Pietra C; Urciuoli M; van Amsterdam FT; Toson G; Gaviraghi G; Trist D J Pharmacol Exp Ther; 1992 Jun; 261(3):1056-63. PubMed ID: 1602372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]